The Increasing Urgency for Standards in Basic Biologic Research
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Research advances build upon the validity and reproducibility of previously published data and findings. Yet irreproducibility in basic biologic and preclinical research is pervasive in both academic and commercial settings. Lack of reproducibility has led to invalidated research breakthroughs, retracted articles, and aborted clinical trials. Concerns and requirements for transparent, reproducible, and translatable research are accelerated by the rapid growth of “post-publication peer review,” open access publishing, and data sharing that facilitate the identification of irreproducible data/studies; they are magnified by the explosion of high-throughput technologies, genomics, and other data-intensive disciplines. Collectively, these changes and challenges are decreasing the effectiveness of traditional research quality mechanisms and are contributing to unacceptable—and unsustainable—levels of irreproducibility. The global oncology and basic biologic research communities can no longer tolerate or afford widespread irreproducible research. This article discusses (i) how irreproducibility in preclinical research can ultimately be traced to an absence of a unifying life science standards framework, and (ii) makes an urgent case for the expanded development and use of consensus-based standards to both enhance reproducibility and drive innovations in cancer research. Cancer Res; 74(15); 4024–9. ©2014 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979 · cited 7×
“As Begley and Ellis (1) note "Unquestionably, a significant contributor to failure in oncology trials is the quality of published preclinical data.”
InfluentialBelieve it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888 · cited 2×
“In 2011, Prinz and colleagues (2) reported”
Policy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247 · cited 8×
“org Cancer Res; 74(15) August 1, 2014 4027”
InfluentialA call for transparent reporting to optimize the predictive value of preclinical research
Landis, S. C., Amara, S. G., Asadullah, K., Austin, C. P., Blumenstein, R., Bradley, E. W., Crystal, R. G., Darnell, R. B., Ferrante, R. J., Fillit, H., et al. (2012) · Nature · doi:10.1038/nature11556 · Cited by 1,196
Rescuing US biomedical research from its systemic flaws
Alberts, B., Kirschner, M. W., Tilghman, S., & Varmus, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404402111 · Cited by 817 · cited 3×
“Under this system, the quality of individual scientists is judged on the basis of their number of publications and citations, particularly in so-called high-impact journals (16).”
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 1×
“laboratories, cross-contamination and errors can occur, resulting in experiments being unintentionally performed on an incorrect cell type (26).”
Toward interoperable bioscience data
Sansone, S.-A., Rocca-Serra, P., Field, D., Maguire, E., Taylor, C., Hofmann, O., Fang, H., Neumann, S., Tong, W., Amaral-Zettler, L., et al. (2012) · Nature Genetics · doi:10.1038/ng.1054 · Cited by 475
Why has the number of scientific retractions increased?
Steen, R. G., Casadevall, A., & Fang, F. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068397 · Cited by 415
Little, R. R., Rohlfing, C. L., & Sacks, D. B. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148841 · Cited by 365
Vasilevsky, N. A., Brush, M. H., Paddock, H., Ponting, L., Tripathy, S. J., LaRocca, G. M., & Haendel, M. A. (2013) · PeerJ · doi:10.7717/peerj.148 · Cited by 271
Cited by
The economics of reproducibility in preclinical research
Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002165 · Cited by 1,055
“However, it is reasonable to state that cumulative errors in the following broad categories—as well as underlying biases that could contribute to each problem area [14] or even result in entire studies never being published or reported [15]—are the primary causes of irreproducibility [16]: (1) study design, (2) biolog…”
BackgroundSelf-citationNon-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
AI for life: Trends in artificial intelligence for biotechnology
Holzinger, A., Keiblinger, K., Holub, P., Zatloukal, K., & Müller, H. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.02.001 · Cited by 438
A systematic approach to quantitative Western blot analysis
Pillai-Kastoori, L., Schutz-Geschwender, A. R., & Harford, J. A. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113608 · Cited by 407
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
Metadata
- Authors
- Freedman, L. P., & Inglese, J.
- Venue
- Cancer Research
- Published
- 2014-07-31
- Volume
- 74
- Issue
- 15
- Pages
- 4024-4029
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2050691291
- Cited by
- 91
- References
- 16
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Increasing Urgency for Standards in Basic Biologic Research. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-0925
- The paper
- Freedman, L. P., & Inglese, J. (2014). The Increasing Urgency for Standards in Basic Biologic Research. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-0925
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.